Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Biomarkers of disease activity in multiple sclerosis.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Daclizumab in multiple sclerosis: a high-yield extension study.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
PML in a patient treated with fumaric acid.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
Visualizing Non-Gaussian Diffusion: Clinical Application of q-Space Imaging and Diffusional Kurtosis Imaging of the Brain and Spine.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?

Pages